PDL BioPharma, Inc.
PDLIV
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 08/31/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | 09/30/2019 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -15.99% | -25.72% | -42.58% | 3.27% |
| Total Receivables | -- | -2.80% | 2.20% | -25.84% | -5.47% |
| Inventory | -- | 19.83% | 30.78% | -61.51% | 28.77% |
| Prepaid Expenses | -- | 33.07% | 199.73% | -37.92% | -15.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -13.02% | 372.88% | 70,266.00% | 0.00% |
| Total Current Assets | -- | -10.11% | 75.62% | -22.85% | 1.80% |
|
|
|||||
| Total Current Assets | -- | -10.11% | 75.62% | -22.85% | 1.80% |
| Net Property, Plant & Equipment | -- | -6.89% | -16.71% | -51.10% | -6.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -2.59% | -2.29% | -96.35% | -1.31% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -58.15% | -96.55% | 6,601.06% | 7.10% |
| Total Assets | -- | -21.09% | -8.00% | -17.10% | -2.84% |
|
|
|||||
| Total Accounts Payable | -- | -32.61% | 95.48% | -79.82% | -10.50% |
| Total Accrued Expenses | -- | 25.52% | -1.05% | -42.87% | 24.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 5.12% | -10.41% |
| Total Finance Division Other Current Liabilities | -- | -24.15% | -17.59% | 252.75% | 9.21% |
| Total Other Current Liabilities | -- | -24.15% | -17.59% | 252.75% | 9.21% |
| Total Current Liabilities | -- | -13.19% | -8.65% | 11.65% | 6.76% |
|
|
|||||
| Total Current Liabilities | -- | -13.19% | -8.65% | 11.65% | 6.76% |
| Long-Term Debt | -- | 1.54% | -51.19% | -79.43% | 3.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -15.58% | -15.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -1.42% | 2.57% | -5.97% | -6.53% |
| Total Liabilities | -- | -5.65% | -13.91% | -45.58% | 1.19% |
|
|
|||||
| Common Stock & APIC | -- | -5.48% | -3.06% | 8.84% | -1.30% |
| Retained Earnings | -- | -21.84% | -7.41% | -8.94% | -2.95% |
| Treasury Stock & Other | -- | 4.26% | 12.38% | 21.45% | -5.69% |
| Total Common Equity | -- | -24.00% | -6.74% | -6.94% | -4.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | -24.00% | -6.74% | -6.94% | -4.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -324.55% | -241.03% | 387.50% | -91.92% |
| Total Equity | -- | -24.07% | -6.77% | -6.93% | -4.21% |
|
|
|||||